title: Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report.
abstract: Chondroblastoma is a rare, benign bone tumor that represents 1-2% of all primary bone tumors. Denosumab, a monoclonal antibody, has been demonstrated to inhibit the growth of giant cell tumors. We report a case of recurrent chondroblastoma of the squamous temporal bone that is currently suppressed with denosumab.
authors.affiliation: Department of Orthopaedic Surgery Sir Charles Gairdner Hospital Nedlands Western Australia 6009 Australia.
authors.forename: Nicholas
authors.identifier: 0000-0002-1232-8631
authors.initials: N
authors.lastname: Calvert
authors.affiliation: Department of Orthopaedic Surgery Sir Charles Gairdner Hospital Nedlands Western Australia 6009 Australia.
authors.forename: David
authors.initials: D
authors.lastname: Wood
keywords: Bone tumor; chondroblastoma; denosumab; giant cell tumor